Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.1991
+0.0064 (3.32%)
At close: May 19, 2026, 4:00 PM EDT
0.2034
+0.0043 (2.16%)
After-hours: May 19, 2026, 7:58 PM EDT
GOSS's stock price has decreased by -80.86% in the past year and price targets may not have had time to catch up.
Gossamer Bio Analyst Ratings
Total Analysts
8
Consensus Rating
Buy
Price Target
$3.55
Upside
+1,683.02%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Maintains $0.3 → $0.28 | Sell | Maintains | $0.3 → $0.28 | +40.63% | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Mar 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $10 → $5 | Strong Buy | Maintains | $10 → $5 | +2,411.30% | Mar 6, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $12 → $3 | Buy | Maintains | $12 → $3 | +1,406.78% | Mar 5, 2026 |
| Wedbush | Wedbush | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +402.26% | Feb 24, 2026 |
| Barclays | Barclays | Buy → Sell Downgrades $9 → $0.3 | Buy → Sell | Downgrades | $9 → $0.3 | +50.68% | Feb 24, 2026 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $6 → $1 | Buy → Hold | Downgrades | $6 → $1 | +402.26% | Feb 24, 2026 |
| Barclays | Barclays | Buy Initiates $9 | Buy | Initiates | $9 | +4,420.34% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +4,922.60% | Jan 22, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 11, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $1.25 → $9 | Hold → Strong Buy | Upgrades | $1.25 → $9 | +4,420.34% | Sep 10, 2025 |
| Wedbush | Wedbush | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +2,411.30% | Aug 6, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $11 | Buy | Initiates | $11 | +5,424.86% | Jul 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +3,918.08% | May 16, 2025 |
| Wedbush | Wedbush | Buy Reiterates $4 | Buy | Reiterates | $4 | +1,909.04% | May 16, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +3,415.82% | Apr 17, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.